Insider Selling: Trupanion, Inc. (NASDAQ:TRUP) CFO Sells $37,698.84 in Stock

Trupanion, Inc. (NASDAQ:TRUP) CFO Fawwad Qureshi sold 828 shares of Trupanion stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $45.53, for a total transaction of $37,698.84. Following the sale, the chief financial officer now directly owns 6,079 shares of the company’s stock, valued at $276,776.87. The trade was a 11.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Trupanion Stock Performance

NASDAQ TRUP opened at $47.20 on Friday. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $2.02 billion, a P/E ratio of -205.22, a P/E/G ratio of 6.02 and a beta of 1.72. Trupanion, Inc. has a 12-month low of $25.90 and a 12-month high of $57.90. The firm has a 50-day moving average price of $39.91 and a two-hundred day moving average price of $43.86.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.02. The company had revenue of $341.98 million during the quarter, compared to analysts’ expectations of $337.81 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The business’s revenue for the quarter was up 11.7% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.16) EPS. Analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Analyst Ratings Changes

TRUP has been the subject of several research analyst reports. Stifel Nicolaus reduced their target price on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Lake Street Capital cut their price objective on shares of Trupanion from $65.00 to $60.00 and set a “buy” rating for the company in a report on Friday, May 2nd. Finally, Piper Sandler cut their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $51.80.

Hedge Funds Weigh In On Trupanion

Several hedge funds and other institutional investors have recently made changes to their positions in TRUP. Barclays PLC raised its position in shares of Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock valued at $2,750,000 after buying an additional 47,262 shares in the last quarter. KBC Group NV acquired a new position in shares of Trupanion in the 4th quarter valued at approximately $75,000. R Squared Ltd acquired a new position in shares of Trupanion in the 4th quarter valued at approximately $79,000. Choreo LLC acquired a new position in shares of Trupanion in the 4th quarter valued at approximately $201,000. Finally, Baillie Gifford & Co. raised its position in shares of Trupanion by 26.6% in the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock valued at $33,806,000 after buying an additional 147,341 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.